Intervention in Individuals at Ultra-High Risk for Psychosis: A Review and Future Directions

Centre for Youth Mental Health, Orygen Youth Health Research Centre, University of Melbourne, Victoria, Australia.
The Journal of Clinical Psychiatry (Impact Factor: 5.14). 07/2009; 70(9):1206-12. DOI: 10.4088/JCP.08r04472
Source: PubMed

ABSTRACT Over the last 15 years, a focus on early intervention in psychotic disorders has emerged. Initially, the early psychosis movement focused on timely recognition and phase-specific treatment of first-episode psychosis. However, early psychosis researchers suspected that pushing the point of intervention even further back to the prodromal phase of psychotic disorders may result in even better outcomes. This article reviews intervention research in the ultra-high-risk phase of psychotic disorders.
A literature search of intervention trials with ultra-high-risk cohorts published after 1980 was conducted on PubMed with the search terms prodrome and intervention.
All published intervention trials with ultra-high-risk cohorts.
The first generation of intervention trials indicated that both pharmacologic and psychological intervention strategies may be of value in terms of symptom reduction and delay or prevention of onset of threshold psychotic disorder.
Further controlled intervention trials with larger sample sizes are required in order to confirm and extend these findings. We argue that the clinical staging model provides a framework for the rationale and design of such studies, with simpler, safer, and more benign interventions being better candidates for first-line treatment, while more complex and potentially harmful treatments should be reserved for those cases in which response has failed to occur. Recent evidence indicates that neuroprotective agents, such as essential fatty acids, may be a suitable form of intervention for the ultra-high-risk phase of psychotic disorders, with a positive risk-benefit balance. Ethical aspects have become more salient given the recently observed declining transition rate in ultra-high-risk samples. We outline the key questions for the next generation of ultra-high-risk intervention trials.

Download full-text


Available from: Merete Nordentoft, Dec 17, 2013
1 Follower
  • Source
    • "Focus on the early detection and intervention in psychosis has spread all over the world in the past 20 years (McGorry, 1993; McGlashan, 1996; Birchwood et al., 1998; Cocchi et al., 2008; McGorry et al., 2009; De Koning et al., 2009). Emphasis on this model has renewed interest in the assessment of vulnerability traits for psychosis in both the schizophrenia and the bipolar disorder spectra (Stefanis et al., 2004; Kwapil et al., 2008; Barrantes-Vidal et al., 2009; 2010; Kwapil et al., 2011; Walsh et al., 2012; Fonseca- Pedrero et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sparse evidence of a co-aggregation of the risk of schizophrenia and bipolar disorder provides support for a shared but nonspecific genetic etiology of bipolar disorder and schizophrenia. Temperaments are conceptualized as trait sub-syndromic conditions of major pathologies. This study set out to test the hypothesis of a continuum between schizotypy and affective temperaments versus the alternative hypothesis of their independence based on a cross-sectional, survey design involving 649 (males: 47%) college students. The short 39-item TEMPS-A and the SPQ were used as measures of the affective temperaments and of schizotypy, respectively. Confirmatory factor analyses were applied to a unidimensional model, to a standard correlate traits model, to second-order representations of a common latent structure, and to a bifactor model. Confirmatory bifactor modeling provided evidence against a complete independence of the dimensions subsumed by the affective and the schizotypal traits. The best solution distinguished between two sub-domains grouping positive symptoms and negative symptoms as measured by the SPQ subscales, and a sub-domain related to the affective temperaments as measured by the TEMPS-A. Limitations due to the use of subscales from two different tools should be taken into account.
    Psychiatry Research 11/2014; 225(1-2). DOI:10.1016/j.psychres.2014.10.027 · 2.68 Impact Factor
  • Source
    • "The left superior temporal gyrus is a biologically plausible neural substrate for disorganized communication as it is critical for language comprehension and production. As dopamine antagonists reverse volume loss in the superior temporal gyrus in first-episode schizophrenia (Keshavan et al., 1998), they might have efficacy in treating disorganized communication and preventing psychosis onset in CHR participants; however, their utility in at-risk cohorts has been limited by side effects and subsequent noncompliance and dropout (McGorry et al., 2009). Remediation strategies to improve communication in CHR participants have not yet been evaluated. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Prior studies have implicated baseline positive and negative symptoms as predictors of psychosis onset among individuals at clinical high risk (CHR), but none have evaluated latent trajectories of symptoms over time. This study evaluated the dynamic evolution of symptoms leading to psychosis onset in a CHR cohort.
    Schizophrenia Research 09/2014; 159(2-3). DOI:10.1016/j.schres.2014.08.008 · 4.43 Impact Factor
  • Source
    • "To Treat or Not to Treat Page 9 of 17 evidence for the benefits of integrative psychotherapy and omega-3 supplements . Some, but not all, anti-psychotic medications have reduced transition rates as well, but have been poorly tolerated by clients (McGorry et al., 2009). The pre-morbid nature of PE complicates early interventions, given the risk for treating false-positives (Larsen et al., 2001), which presents an ethical dilemma that weighs the reduced duration of untreated psychosis against the excessive treatment of healthy individuals. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Psychotic experiences (PE) have been found to be much more common in the general population than psychotic disorders, yet research is currently ambivalent about whether or not PE warrant clinical treatment, and what treatment should entail. In light of this dilemma,wereviewthe definitions of PEandhowthey differ fromtworelated sub-threshold phenomena, which are ‘clinical high risk’ and ‘voice hearing’. Thenwe discuss the clinical significance of PE with respect to three areas: (i) the risk of transitioning from PE to threshold psychotic disorder, (ii) the distress and impairment associated with PE irrespective of transition and (iii) the treatment-seeking behaviours and need for care of people with PE. Finally, we consider the implications for social work practice and underscore the importance of a person-centred treatment system to detect and respond to PE while working with social support systems.
    British Journal of Social Work 01/2014; DOI:10.1093/bjsw/bct199 · 1.19 Impact Factor
Show more